相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study
Tanya Babich et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalization
I Lopez-Montesinos et al.
JOURNAL OF INFECTION (2020)
A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections
Qingyi Shi et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States
Y. P. Tabak et al.
JOURNAL OF HOSPITAL INFECTION (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis
Zhihui Chen et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2019)
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013
Alessandro Cassini et al.
EUROSURVEILLANCE (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
Carlos Juan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
Christopher Troeger et al.
LANCET INFECTIOUS DISEASES (2017)
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States
S. M. Bartsch et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients
William R. Judd et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2016)
Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study
Alessandro Cassini et al.
PLOS MEDICINE (2016)
Disability adjusted life year (DALY): A useful tool for quantitative assessment of environmental pollution
Tingting Gao et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2015)
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Hospital economic impact of an outbreak of Pseudomonas aeruginosa infections
R. Bou et al.
JOURNAL OF HOSPITAL INFECTION (2009)
Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia
CI Kang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
分享论文
